GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » ROC (Joel Greenblatt) %

ITGR (Integer Holdings) ROC (Joel Greenblatt) % : 24.61% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Integer Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 24.61%.

The historical rank and industry rank for Integer Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

ITGR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 3.58   Med: 22.77   Max: 30.73
Current: 23.38

During the past 13 years, Integer Holdings's highest ROC (Joel Greenblatt) % was 30.73%. The lowest was 3.58%. And the median was 22.77%.

ITGR's ROC (Joel Greenblatt) % is ranked better than
76% of 850 companies
in the Medical Devices & Instruments industry
Industry Median: -0.525 vs ITGR: 23.38

Integer Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -9.20% per year.


Integer Holdings ROC (Joel Greenblatt) % Historical Data

The historical data trend for Integer Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings ROC (Joel Greenblatt) % Chart

Integer Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.73 23.89 24.19 17.83 21.64

Integer Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.80 25.96 18.30 24.33 24.61

Competitive Comparison of Integer Holdings's ROC (Joel Greenblatt) %

For the Medical Devices subindustry, Integer Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Integer Holdings's ROC (Joel Greenblatt) % falls into.



Integer Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(240.504 + 272.335 + 23.72) - (197.262 + 0 + 2.8421709430404E-14)
=339.297

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(241.708 + 265.415 + 79.832) - (203.546 + 0 + 4.969)
=378.44

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Integer Holdings for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=227.632/( ( (564.19 + max(339.297, 0)) + (568.144 + max(378.44, 0)) )/ 2 )
=227.632/( ( 903.487 + 946.584 )/ 2 )
=227.632/925.0355
=24.61 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integer Holdings  (NYSE:ITGR) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Integer Holdings ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Integer Holdings's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Integer Holdings Business Description

Traded in Other Exchanges
N/A
Address
5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.
Executives
Jean M. Hobby director 10000 WEHRLE DRIVE, CLARENCE NY 14031
Martin C Maxwell director PARKER HANNIFIN CORPORATION, 6035 PARKLAND BLVD, CLEVELAND OH 44124
John A Harris officer: VP, Operations Cardio & Vascul 10000 WEHRLE DRIVE, CLARENCE NY 14031
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Payman Khales officer: President, C&V 10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn officer: SVP, Strategy and Business Dev 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Tommy P Thomas officer: VP, Corporate Controller 10000 WEHRLE DRIVE, CLARENCE NY 14031
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jim Stephens officer: President, CRM & Neuro 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith officer: VP, Interim CFO 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic director 1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey director 1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Marshall Mcalister C Ii officer: SVP, Gen Counsel & Secretary 1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226